Aytu Bio sells Primsol to Allegis for $1.75M

|About: Aytu BioScience, Inc. (AYTU)|By:, SA News Editor

Aytu BioScience (OTCQX:AYTU +1.2%) divests Primsol, an oral antibiotic solution for urinary tract infections, to Allegis Holdings,LLC for $1.75M in cash. Aytu will use the proceeds to fund the ongoing U.S. launch of Natesto.